ArticleInternational journal of molecular sciences2025
The Characterization and Antioxidant and Erythroprotective Effects of β-Carotene Complexed in β-Cyclodextrin.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Effect of Water Vapor Generated by Fresh-Cut Mango (Molecules (Basel, Switzerland) · 2026Article
- β-Cyclodextrin Inclusion Complexes ofPharmaceutics · 2026Article
- Exploring Cyclodextrin Complexes of Lipophilic Antioxidants: Benefits and Challenges in Nutraceutical Development.International journal of molecular sciences · 2025Review
- Modified Castor Oil-Based Polyurethane Films withPolymers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
β-carotene (β-C) is a hydrophobic compound, easily degradable by light and oxygen and with low solubility, limiting its applications. β-cyclodextrin (β-CD) can encapsulate β-C, protecting it from degradation and maintaining its bioactivity. Therefore, this research aimed to characterize and determine the antioxidant and erythroprotective activity of β-C/β-CD inclusion complexes. The co-precipitation technique was used to elaborate β-C/β-CD in a 40:60 ratio, obtaining a high yield (94.10%), an entrapment efficiency of 82.47%, and a loading efficiency of 11.92%. The moisture of β-C/β-CD was 2.93%. β-C release increased over the time of 216 h (80.8%, 92.8%, and 97.4% at 8 °C, 25 °C, and 37 °C, respectively). A UV-visible analysis confirmed the presence of β-carotene in the inclusion complex, indicating successful encapsulation without significant structural changes. According to the adsorption-desorption isotherms, the complexes showed a type II isotherm. The FT-IR and Raman spectroscopy confirmed the formation of the inclusion complex, which interacted by hydrogen bonds, hydrophobic interactions, or van der Waals forces. The DSC showed an endothermic peak at 118 °C in the β-C/β:CD. The TGA revealed reduced water loss in the β-carotene/β-cyclodextrin complex, indicating limited water binding due to encapsulation. The microscopic surface morphologies observed by the SEM of β-C/β-CD were irregular-shaped clumps in the surface with a particle average size of 8.09 µm. The X-ray diffraction showed a crystalline structure of the complex. The zeta potential determination indicated a negative charge (-23 and -32 mV). The ABTS, DPPH, and FRAP demonstrated the antioxidant activity of β-C/β:CD (34.09%, 21.73%, and 8.85. mM ET/g, respectively), similar to pure β-C (34.64%, 22.63%, and 9.12 μM ET/g, respectively). The complexes showed an erythroprotective effect inhibiting hemolysis (64.09%). Therefore, with these characteristics, β-CD is a good encapsulant for β-C, and this complex could be applied in the food and pharmaceutical industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.